{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:38:23Z","timestamp":1782603503805,"version":"3.54.5"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2015.77","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T14:12:22Z","timestamp":1443795142000},"page":"e351-e351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib"],"prefix":"10.1038","volume":"5","author":[{"given":"A","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"Knoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E K","family":"Engle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A C","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S T","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"key":"BFbcj201577_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.leu.2404955","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14\u201322.","journal-title":"Leukemia"},{"key":"BFbcj201577_CR2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1182\/blood-2012-11-467787","volume":"121","author":"X Wang","year":"2013","unstructured":"Wang X, Tripodi J, Kremyanskaya M, Blouin A, Roda P, Hoffman R et al. BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia. Blood 2013; 121: 1238\u20131239.","journal-title":"Blood"},{"key":"BFbcj201577_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S1470-2045(07)70295-4","volume":"8","author":"M Bocchia","year":"2007","unstructured":"Bocchia M, Vannucchi AM, Gozzetti A, Guglielmelli P, Poli G, Crupi R et al. Insights into JAK2-V617F mutation in CML. Lancet Oncol 2007; 8: 864\u2013866.","journal-title":"Lancet Oncol"},{"key":"BFbcj201577_CR4","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1016\/j.leukres.2009.06.011","volume":"33","author":"L Campiotti","year":"2009","unstructured":"Campiotti L, Appio L, Solbiati F, Ageno W, Venco A . JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia. Leuk Res 2009; 33: e212\u2013e213.","journal-title":"Leuk Res"},{"key":"BFbcj201577_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/sj.leu.2404993","volume":"22","author":"K Hussein","year":"2008","unstructured":"Hussein K, Bock O, Theophile K, Seegers A, Arps H, Basten O et al. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation. Leukemia 2008; 22: 1059\u20131062.","journal-title":"Leukemia"},{"key":"BFbcj201577_CR6","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.leu.2405088","volume":"22","author":"N Cambier","year":"2008","unstructured":"Cambier N, Renneville A, Cazaentre T, Soenen V, Cossement C, Giraudier S et al. JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia 2008; 22: 1454\u20131455.","journal-title":"Leukemia"},{"key":"BFbcj201577_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12185-009-0471-6","volume":"91","author":"PC Bee","year":"2010","unstructured":"Bee PC, Gan GG, Nadarajan VS, Latiff NA, Menaka N . A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders. Int J Hematol 2010; 91: 136\u2013139.","journal-title":"Int J Hematol"},{"key":"BFbcj201577_CR8","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.3816\/CLM.2009.n.080","volume":"9","author":"SR Pingali","year":"2009","unstructured":"Pingali SR, Mathiason MA, Lovrich SD, Go RS . Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation. Clin Lymphoma Myeloma 2009; 9: E25\u2013E29.","journal-title":"Clin Lymphoma Myeloma"},{"key":"BFbcj201577_CR9","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.3324\/haematol.2013.102525","volume":"99","author":"A Iurlo","year":"2014","unstructured":"Iurlo A, Gianelli U, Rapezzi D, Cattaneo D, Fermo E, Binda F et al. Imatinib and ruxolitinib association: first experience in two patients. Haematologica 2014; 99: e76\u2013e77.","journal-title":"Haematologica"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201577","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:03:25Z","timestamp":1672913005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":9,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10]]}},"alternative-id":["BFbcj201577"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2015.77","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]},"assertion":[{"value":"2 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}